Mural Oncology’s (MURA) “Buy” Rating Reaffirmed at HC Wainwright
Mural Oncology (NASDAQ:MURA – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 391.80% from the company’s previous close. Mural Oncology […]
Mural Oncology (NASDAQ:MURA – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 391.80% from the company’s previous close. Mural Oncology […]
